Fri Aug 4 16:36:35 2006
Complete replication of hepatitis C virus in cell culture
Lindenbach BD, Evans MJ, Syder AJ, et al.
SCIENCE 309 (5734): 623-626 JUL 22 2005
and the citing papers
stopwords, and 2-character and smaller words are excluded, Word count: 639, All words count: 954
Grand TLCS: 116, Grand TGCS: 195| View: Overview | Sorted by LCS. |
Page 2 of 2: [ 1 2 ]
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 201 | HORSE | 1 | 0 | 0
|
| 202 | HOST | 1 | 0 | 0
|
| 203 | IDENTIFY | 1 | 0 | 0
|
| 204 | IMMORTALIZED | 1 | 0 | 0
|
| 205 | IMMUNE | 1 | 0 | 0
|
| 206 | IMMUNITY | 1 | 0 | 2
|
| 207 | IMPLICATION | 1 | 0 | 0
|
| 208 | INDEPENDENT | 1 | 0 | 0
|
| 209 | INDUCED | 2 | 0 | 0
|
| 210 | INFECTION | 2 | 0 | 0
|
| 211 | INHIBIT | 1 | 0 | 0
|
| 212 | INHIBITION | 2 | 0 | 1
|
| 213 | INHIBITORS | 2 | 0 | 0
|
| 214 | INNATE | 2 | 0 | 2
|
| 215 | INSERTION | 1 | 0 | 0
|
| 216 | INSIGHTS | 1 | 0 | 0
|
| 217 | INTERACTION | 2 | 0 | 0
|
| 218 | INTERFERENCE-MEDIATED | 1 | 0 | 0
|
| 219 | INTERFERING | 1 | 0 | 2
|
| 220 | INTERFERONS | 1 | 0 | 2
|
| 221 | INTERGENOTYPIC | 1 | 0 | 0
|
| 222 | INTERNAL | 1 | 0 | 0
|
| 223 | INTRACELLULAR | 1 | 0 | 0
|
| 224 | INTRAGENOTYPIC | 1 | 0 | 0
|
| 225 | KETOAMIDE | 1 | 0 | 0
|
| 226 | LDL-R | 1 | 0 | 0
|
| 227 | LINE | 1 | 0 | 0
|
| 228 | LIPOPROTEINS | 2 | 0 | 0
|
| 229 | LIVER | 3 | 0 | 0
|
| 230 | LUCIFERASE | 2 | 0 | 0
|
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 231 | MATURATION | 1 | 0 | 0
|
| 232 | MEASUREMENT | 1 | 0 | 0
|
| 233 | MECHANISM-BASED | 1 | 0 | 0
|
| 234 | MECHANISMS | 2 | 0 | 0
|
| 235 | MEDIATED | 1 | 0 | 0
|
| 236 | MEMBRANES | 1 | 0 | 0
|
| 237 | MENACE | 1 | 0 | 0
|
| 238 | MILESTONE | 1 | 0 | 0
|
| 239 | MODELING | 1 | 0 | 0
|
| 240 | MODULATES | 1 | 0 | 0
|
| 241 | MONOCLONAL | 1 | 0 | 0
|
| 242 | MORPHOGENESIS | 1 | 0 | 0
|
| 243 | MOVE | 1 | 0 | 0
|
| 244 | MUTAGENESIS | 1 | 0 | 0
|
| 245 | MUTAGENIC | 1 | 0 | 2
|
| 246 | NATURAL | 1 | 0 | 0
|
| 247 | NEUTRALIZING | 1 | 0 | 0
|
| 248 | NEW | 3 | 0 | 0
|
| 249 | NON-IMMUNOSUPPRESSIVE | 1 | 0 | 0
|
| 250 | NON-STRUCTURAL | 1 | 0 | 0
|
| 251 | NONSTRUCTURAL | 1 | 0 | 0
|
| 252 | NS34A | 1 | 0 | 0
|
| 253 | NS5B | 1 | 0 | 0
|
| 254 | NS5B-NUCLEOLIN | 1 | 0 | 0
|
| 255 | NUMBER | 1 | 0 | 0
|
| 256 | OLIGONUCLEOTIDE-BASED | 1 | 0 | 0
|
| 257 | OPIATE | 1 | 0 | 0
|
| 258 | OPTIONS | 1 | 0 | 0
|
| 259 | OXLDL | 1 | 0 | 0
|
| 260 | PARALLEL | 1 | 0 | 0
|
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 261 | PARTICLE | 1 | 0 | 0
|
| 262 | PARTICLES | 4 | 0 | 0
|
| 263 | PEPTIDASE | 1 | 0 | 0
|
| 264 | PEPTIDE | 2 | 0 | 0
|
| 265 | PHANTOM | 1 | 0 | 0
|
| 266 | POLYPROTEIN | 1 | 0 | 0
|
| 267 | POTENT | 2 | 0 | 0
|
| 268 | POTENTIAL | 3 | 0 | 0
|
| 269 | PRACTICE | 1 | 0 | 1
|
| 270 | PREVENTION | 1 | 0 | 0
|
| 271 | PRIMARY | 1 | 0 | 0
|
| 272 | PRODUCED | 1 | 0 | 0
|
| 273 | PROFILES | 1 | 0 | 0
|
| 274 | PROMOTE | 1 | 0 | 0
|
| 275 | PROPERTIES | 1 | 0 | 0
|
| 276 | PROTEASE | 3 | 0 | 0
|
| 277 | PROTEASE-DEPENDENT | 1 | 0 | 0
|
| 278 | PSEUDOPARTICLE | 1 | 0 | 0
|
| 279 | RAT | 1 | 0 | 0
|
| 280 | REARRANGEMENT | 1 | 0 | 0
|
| 281 | RECENT | 1 | 0 | 1
|
| 282 | RECEPTOR | 2 | 0 | 0
|
| 283 | RECEPTORS | 2 | 0 | 0
|
| 284 | REGIONS | 1 | 0 | 0
|
| 285 | REPLICONS | 1 | 0 | 0
|
| 286 | REPORTER | 2 | 0 | 0
|
| 287 | REQUIRED | 1 | 0 | 0
|
| 288 | RESEARCH | 1 | 0 | 0
|
| 289 | RESPONSES | 2 | 0 | 0
|
| 290 | ROLE | 1 | 0 | 0
|
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 291 | SAR | 1 | 0 | 0
|
| 292 | SCAVENGER | 2 | 0 | 0
|
| 293 | SCH | 2 | 0 | 0
|
| 294 | SECRETION | 1 | 0 | 0
|
| 295 | SERINE | 1 | 0 | 0
|
| 296 | SHORT | 1 | 0 | 0
|
| 297 | SIGNAL | 2 | 0 | 0
|
| 298 | SIGNALING | 1 | 0 | 0
|
| 299 | SIGNALS | 1 | 0 | 0
|
| 300 | SIMULTANEOUS | 1 | 0 | 0
|
| 301 | SINUSOIDAL | 1 | 0 | 0
|
| 302 | SR-BI | 1 | 0 | 0
|
| 303 | STAGES | 1 | 0 | 0
|
| 304 | STATINS | 1 | 0 | 0
|
| 305 | STEPS | 1 | 0 | 0
|
| 306 | STIMULATING | 1 | 0 | 0
|
| 307 | STRATEGIES | 1 | 0 | 0
|
| 308 | STRUCTURE | 1 | 0 | 0
|
| 309 | SUBGENOMIC | 2 | 0 | 0
|
| 310 | SUPPRESSES | 1 | 0 | 0
|
| 311 | SYNTHESIS | 1 | 0 | 0
|
| 312 | TARGET | 1 | 0 | 0
|
| 313 | TARGETING | 1 | 0 | 0
|
| 314 | TETRASPANIN | 1 | 0 | 0
|
| 315 | THERAPEUTIC | 3 | 0 | 0
|
| 316 | THERAPIES | 1 | 0 | 0
|
| 317 | THERAPY | 4 | 0 | 0
|
| 318 | THIENYL | 1 | 0 | 0
|
| 319 | THREE-DIMENSIONAL | 1 | 0 | 0
|
| 320 | TOLL-LIKE | 1 | 0 | 0
|
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 321 | TRACT | 1 | 0 | 0
|
| 322 | TRANSLATION | 1 | 0 | 1
|
| 323 | TRIGGER | 1 | 0 | 0
|
| 324 | TROJAN | 1 | 0 | 0
|
| 325 | TWO | 1 | 0 | 0
|
| 326 | TWO-AND | 1 | 0 | 0
|
| 327 | UPTAKE | 1 | 0 | 0
|
| 328 | USING | 2 | 0 | 0
|
| 329 | VECTORS | 1 | 0 | 0
|
| 330 | VIABLE | 1 | 0 | 0
|
| 331 | VIROLOGIC | 1 | 0 | 1
|
| 332 | VIROLOGY | 1 | 0 | 0
|
| 333 | VIRUS-INFECTED | 1 | 0 | 0
|
| 334 | VIRUS-LIKE | 2 | 0 | 0
|
| 335 | VIRUS-NEUTRALIZING | 1 | 0 | 0
|
| 336 | VIRUSES | 2 | 0 | 0
|
Page 2 of 2: [ 1 2 ]